InflaRx Submits Request for Emergency Use Authorization to US FDA for Vilobelimab for Treatment of Critically Ill COVID-19 Patients Read more
Ventus Therapeutics Enters Exclusive Development and License Agreement with Novo Nordisk for NLRP3 Inhibitor Program Read more
Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares Read more
MODERNA SUES PFIZER AND BIONTECH FOR INFRINGING PATENTS CENTRAL TO MODERNA’S INNOVATIVE MRNA TECHNOLOGY PLATFORM Read more
Dupixent (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis Read more
Thermo Fisher Scientific Launches a More Sustainable Solution for Large-Scale Cell Culture Harvesting Read more
Verismo Therapeutics Receives FDA Orphan Drug Designation for SynKIR-110, a First-in-Class KIR-CAR T Cell Immunotherapy Candidate, for the Treatment of Mesothelioma Read more